We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Successfully introduce transgenes using the Safe Harbor system

Product News   May 07, 2015

 
Successfully introduce transgenes using the Safe Harbor system
 
 
Advertisement
 

Related Product News

PerkinElmer Launches No-Wash Immunoassay for Neuroscience Disease and Therapeutics Research

Product News

PerkinElmer, Inc., today launched the life science industry’s first no-wash Ubiquitin phosphorylation at Serine 65 immunoassay that is aimed at helping scientists discover new therapeutic candidates earlier in the disease cycle.

READ MORE

Impel Neuropharma Presents Data for the 2020 Migraine Trust Virtual Symposium

Product News

Impel NeuroPharma announced that it has presented patient-reported outcomes data from the Company’s pivotal Phase 3, open-label study “STOP 301” of INP104 (dihydroergotamine mesylate) or DHE using the company’s proprietary POD technology, for the treatment of acute migraine in an oral presentation at the Migraine Trust Virtual Symposium (MTIS) to be held from October 3-9, 2020.

READ MORE

Cobra Biologics Delivers Final Plasmids for Production of CG01 in CombiGene's Epilepsy Project

Product News

The milestone in the project paves the way for production of novel gene therapy drug candidate designed to treat drug-resistant focal epilepsy.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE